Metformin Is Associated with Reduced Tissue Factor Procoagulant Activity in Patients with Poorly Controlled Diabetes

PURPOSE: Metformin is the first-line antidiabetic drug and shown to reduce cardiovascular risk independent from its glucose lowering action. Particularly in poorly controlled diabetes, tissue factor (TF) is expressed in the vasculature and accounts for thromboembolic complications. Here, we aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Witkowski, Marco, Friebel, Julian, Tabaraie, Termeh, Grabitz, Sinah, Dörner, Andrea, Taghipour, Lena, Jakobs, Kai, Stratmann, Bernd, Tschoepe, Diethelm, Landmesser, Ulf, Rauch, Ursula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266708/
https://www.ncbi.nlm.nih.gov/pubmed/32940892
http://dx.doi.org/10.1007/s10557-020-07040-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266708/
https://www.ncbi.nlm.nih.gov/pubmed/32940892
http://dx.doi.org/10.1007/s10557-020-07040-7

Ejemplares similares